Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

State, local access to federal device contracts would cost $1.35 bil. a year -- HIMA rep.

This article was originally published in The Gray Sheet

Executive Summary

STATE, LOCAL PARTICIPATION IN FEDERAL MEDICAL DEVICE CONTRACTS WOULD ADD $1.35 BIL. in annual costs to the federal government, according to results of a study released by Thomas Gunerman, president and CEO of Intersurgical, at a July 27 hearing before the House Committee on Small Business. Gunerman, who represented the Health Industry Manufacturers Association, cited a study conducted by Muse & Associates at HIMA's request which suggested that federal government cost increases experienced with the Medicaid prescription drug rebate program would be repeated for devices under Sec. 1555 of the Federal Acquisition Streamlining Act of 1994 (FASA).
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004514

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel